|
No.50
Cat-scratch
disease
|
|
By Soichi Maruyama, Associate
Professor, Research Department, Veterinary Public Health,
Veterinary Science, College of Bioresource Sciences, Nihon
University
|
 |
|
1. Pathogenic agent of cat-scratch disease (CSD)
The pathogen of cat-scratch disease is
Bartonella henselae, a gram-negative polymorphic bacillus. It
has been reported that B.clarridgeiae
of the same genus also causes typical or atypical CSD in humans.
2. Epidemiology of CSD
The annual number of CSD patients in the
United States was around 22,000 in 1992, and the annual incidence
of CSD is 0.77~0.88 per 100,000 persons. The annual incidence
of patients in the Connecticut state is estimated at 3.7/100,000
people. In Japan, since this sickness was reported for the first
time by Hamaguchi et al. in 1953, CSD cases have been occasionally
found. However no statistics are available on the number of CSD
patients throughout Japan.
CSD occurs in all age groups, but young age group is the majority.
A report on the study of 63 CSD cases in Japan shows that over
60% of all the patients are females, in particular in their teens
and in their forties, and that in children under the age of 9,
the disease tends to strike more frequently boys than girls.
CSD occurs frequently from July to December
or from fall through winter. The number of cats infected by the
disease rises during the period of cat-flea reproduction in the
summertime. Later on when the season turns cold, those cats stay
more often in homes, and the number of cases increases presumably
because cat owners are more liable to get scratched and injured.
An important etiologic source or infection source of the disease
is assumedly infected kittens below 12 months of age or kittens
infested with many fleas. Fleas become vectors of B.henselae amongst
these animals. Infection due to wounds apparently occurs between
cats or from cats to humans, since B.henselae is excreted in the
buccal cavity for some reasons in cats or the bacterium shed in
the feces of fleas adheres to the teeth or to the claws during
grooming, and the infected fleas are ingested in the mouth and
the cats become infected by the bacillus.
Though it is not clear at present that
B.henselae infection is passed from fleas to humans, it would
be possible to consider that fleas having sucked the blood of
infected cats transmit the bacterium to humans. In Japan, 8.8%
of domestic cats (128/1,447) are antibody-positive. A high positiveness
rate is found in young cats, cats that were infested by fleas,
cats kept outdoors and also those staying in warm areas in the
south region of Japan. Besides 7.2% of the Japanese domestic cats
(50/690) are carriers of the Bartonella bacterium. The rate is
ranged from 2% to 20%, and differences are noted between regions.
This rate tends to be high in cats staying in southern warm regions
and urban areas. The status of infection of cats in Japan may
be related to the distribution of cat fleas and to the frequency
of occasions of exposure to infected cats. The distribution of
B.clarridgeiae is also manifest in cats in Japan.
3. Symptoms
1)Humans
In typical CSD, lesions similar to insect
bites are formed at the site of invasion by the bacterium (usually,
fingers and forearms) 3~10 days after being scratched by a cat.
In some cases, papules may turn into blisters, and some of them
may suppurate or develop into ulcers. Swollen localized lymph
nodes (in the majority, inguinal region, axilla or cervical lymph
nodes) appear one or two weeks after the formation of these lesions.
Usually lymphadenitis is unilateral and is accompanied by pain,
and it persists from several weeks to several months. Many subjects
exhibit fever, chills, tiredness, loss of appetite, headache,
etc. However these symptoms are generally benign and recover naturally.
Atypical CSD symptoms are manifested in
5~10% of the subjects. Parinaud's syndrome (inflammation of the
lymph glands in the periphery of the ears, palpebral conjunctivitis,
etc.), encephalitis, osteolytic lesions, endocarditis, granulomatous
hepatitis, etc. have been reported. Bacterial hemangioma occurs
in case immunocompromised subjects are infected by B. henselae.
Its clinical manifestation is purple or colorless vesicles or
cystic skin lesions such as Kaposi's sarcoma, and in some cases
cysts may spread to the parenchymal organs.
2) Cats
Cats infected by B.henselae are bacteremic
for a long duration (several months to several years) without
normally exhibiting any clinical symptoms. Cases of fever, transient
neurological dysfunction, somnolence, anorexia, etc. have been
reported in cats experimentally infected with B. henselae.
4. Diagnosis
When diagnosing CSD, it is necessary to
check for contacts with cats (notably young cats) and to confirm
the presence of wounds and swollen local lymph nodes. The indirect
fluorescent antibody technique using B. henselae as antigen is
employed as a serological diagnostic tool. With this technique,
the subject is determined to be positive in case the antibody
titer in the serum shows a 64-fold or more elevation.
Blood and lymph node materials are used
for the isolation of B. henselae. However the isolation of the
bacterium from patients is extremely difficult. Blood agar
culture medium is used for the isolation and cultivation is performed
at 35~37oC in 5% CO2 vapor phase. In case of primary isolation
culture, it is necessary to continue the observation for four
weeks. The technique consisting of comparing the cleavage
patterns of the PCR amplification products of citric acid synthesis
enzyme genes using two restriction enzymes, Taql, Hhal and
strain specific PCR are used for the identification of the bacterial
strain.
5. Treatment
Treatment by means
of various antibacterials has been experimented for typical CSD,
but their efficacy is not so high. Antibiotics such as erythromycin,
rifampicin, gentamycin, doxycycline, ciprofloxacin, etc. are efficacious
against bacterial angioma in immunocompromised patients. In cats,
antibiotics such as doxycycline, lincomycin, amoxicillin, etc.
can inhibit bacteremia to some extent. However they cannot
eliminate completely the bacterium from the blood.
6. Prevention
There are no other
means than taking general hygienic precautions such as 1) avoiding
scratches from cats (notably kittens); 2)disinfection of wounds
caused by cats; 3) washing hands after exposure to cats; 4) getting
rid of cat fleas, etc. There are no vaccines for cats and humans.
When keeping cats in households with children, it should be recommended
to have cats on which fleas have been exterminated and cats negative
for B.henselae bacteremia. In addition, immune compromised persons
should avoid contacts with cats and keeping cats at home.
|
| <
back |
INDEX
 |
Next
> |
|